Mahul Amin, MD, Named Chair of the Department of Pathology at UTHSC

|
Dr. Mahul Amin is the new chair of the Department of Pathology in the College of Medicine at UT Health Science Center.

Mahul Amin, MD, has been named chair of the Department of Pathology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC). He will also be the UTHSC Gerwin Chair for cancer research. Dr. Amin comes to UTHSC from Cedars-Sinai Medical Center, where he was chairman and professor of Pathology and Laboratory Medicine. He was also a professor of Pathology and Laboratory Medicine at the University of California David Geffen School of Medicine.

“We’re pleased to have Dr. Amin join us,” said David Stern, MD, Robert Kaplan Executive Dean of the UTHSC College of Medicine. “I have every expectation that he will lead us in taking clinical pathology to the next level at UTHSC and throughout the region. Further, Dr. Amin will create a stimulating learning environment for the next generation of graduate students and pathologists in training. He wants to make UTHSC the premier place to train for pathology.”

Under Dr. Amin’s leadership, the Department of Pathology and Laboratory Medicine at Cedars-Sinai was selected “Lab of the Year 2014” by Medical Laboratory Observer, a national magazine. Since 2002, he has been listed in “The Best Doctors in America.” From 2001 to 2009 – first as vice chair and then as chair of the Cancer Committee of the College of American Pathologists (CAP) – he campaigned for a standardized system for pathologic reporting of all cancer cases in the United States. Dr. Amin also earned the 2010 CAP Foundation Lansky Award and the 2010 CAP Distinguished Service Award.

Dr. Amin is the editor-in-chief of the eighth edition of the American Joint Commission on Cancer TNM staging system, which is the premier global classifier for cancer and is used worldwide in clinical decision-making for all patients with cancer and to define clinical and translational research and health care policy in cancer.

He is a national and international consultant for the diagnosis of urologic cancers, having co-authored the 2002 and 2016 World Health Organization classification systems for genitourinary cancers.

Dr. Amin said UTHSC is attractive because it is “in an extraordinary transformational phase” with “a growing research environment.” He added, “Advances in science, genomics, informatics and laboratory medicine also provide a once-in-a-lifetime opportunity for the discipline of pathology, which is also experiencing its most exciting and transformative phase.”

According to Dr. Amin, the UTHSC Department of Pathology has all of the major components of a world-class, clinically-focused academic department. “These include very talented pathologists in the various UTHSC partner hospitals and affiliated departments, including St. Jude and the VA; faculty involved in basic sciences research and extramural funding, and a strong graduate medical education program with residents and fellows. We are uniquely positioned to develop a translational research program, and to help UTHSC in a system-wide Precision Medicine initiative.

“The overarching goal is to create a big, inclusive tent that brings together individuals with diverse strengths and professional backgrounds,” he said.